Ovis aries strain OAR_USU_Benz2616 breed Rambouillet chromosome 16, ARS-UI_Ramb_v2.0, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae; Caprinae; Ovis.
REFSEQ INFORMATION: The reference sequence is identical to\nCM028719.1.\nAssembly name: ARS-UI_Ramb_v2.0\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the University of Idaho on\n2021/02/03. The original whole-genome shotgun project has the\naccession JAEVFA000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: University of Idaho\nAssembly Date :: NOV-2020\nAssembly Method :: Canu v. 1.8; Nanopolish v. 0.12.5; Salsa\n v. 2.2; PB Jelly v. 15.8.24; Freebayes v.\n 1.3.1\nAssembly Name :: ARS-UI_Ramb_v2.0\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 55.0x\nSequencing Technology :: Oxford Nanopore PromethION; PacBio RSII;\n Illumina HiSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Ovis aries Annotation Release 104\nAnnotation Version :: 104\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
ankyrin repeat domain-containing protein 26-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 16% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 1 base in 1 codon; substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: ankyrin repeat domain-containing protein 26-like
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 19% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC121816782, transcript variant X2
uncharacterized LOC121816782, transcript variant X1
COORDINATES: cap analysis [ECO:0007248] and polyA evidence [ECO:0006239]
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 43% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
POU domain, class 5, transcription factor 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 8 Proteins, and 57% coverage of the annotated genomic feature by RNAseq alignments
microRNA mir-103; Derived by automated computational analysis using gene prediction method: BestRefSeq.
Derived by automated computational analysis using gene prediction method: BestRefSeq.
microRNA mir-218a; Derived by automated computational analysis using gene prediction method: BestRefSeq.
SAP domain-containing ribonucleoprotein-like
spindle apparatus coiled-coil protein 1, transcript variant X5
spindle apparatus coiled-coil protein 1, transcript variant X1
spindle apparatus coiled-coil protein 1, transcript variant X4
spindle apparatus coiled-coil protein 1, transcript variant X3
spindle apparatus coiled-coil protein 1, transcript variant X2
heterogeneous nuclear ribonucleoprotein A1-like
COORDINATES: polyA evidence [ECO:0006239]
inhibitory synaptic factor family member 2B, transcript variant X1
inhibitory synaptic factor family member 2B, transcript variant X2
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA cysteine (anticodon GCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
putative uncharacterized protein C5orf58 homolog
lymphocyte cytosolic protein 2, transcript variant X2
lymphocyte cytosolic protein 2, transcript variant X1
lymphocyte cytosolic protein 2, transcript variant X3
lymphocyte cytosolic protein 2 isoform X2
lymphocyte cytosolic protein 2 isoform X1
lymphocyte cytosolic protein 2 isoform X3
uncharacterized LOC121816783, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC121816783, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
uncharacterized LOC121816783, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
potassium voltage-gated channel interacting protein 1, transcript variant X1
Kv channel-interacting protein 1 isoform X1
potassium calcium-activated channel subfamily M regulatory beta subunit 1, transcript variant X1
calcium-activated potassium channel subunit beta-1 isoform X1
potassium calcium-activated channel subfamily M regulatory beta subunit 1, transcript variant X2
calcium-activated potassium channel subunit beta-1 isoform X2
potassium voltage-gated channel interacting protein 1, transcript variant X2
potassium voltage-gated channel interacting protein 1, transcript variant X3
Kv channel-interacting protein 1 isoform X2
Kv channel-interacting protein 1 isoform X3
potassium voltage-gated channel interacting protein 1, transcript variant X4
Kv channel-interacting protein 1 isoform X4
gamma-aminobutyric acid type A receptor subunit pi, transcript variant X1
gamma-aminobutyric acid type A receptor subunit pi, transcript variant X2
gamma-aminobutyric acid type A receptor subunit pi, transcript variant X3
gamma-aminobutyric acid type A receptor subunit pi, transcript variant X4
gamma-aminobutyric acid receptor subunit pi isoform X1
gamma-aminobutyric acid receptor subunit pi isoform X3
gamma-aminobutyric acid receptor subunit pi isoform X2
RAN binding protein 17, transcript variant X5
RAN binding protein 17, transcript variant X1
RAN binding protein 17, transcript variant X6
RAN binding protein 17, transcript variant X3
RAN binding protein 17, transcript variant X2
RAN binding protein 17, transcript variant X4
RAN binding protein 17, transcript variant X9
RAN binding protein 17, transcript variant X8
RAN binding protein 17, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, 7 Proteins, and 51% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC114118717, transcript variant X1
uncharacterized LOC114118717, transcript variant X2
uncharacterized LOC121816785, transcript variant X4
uncharacterized LOC121816785, transcript variant X1
uncharacterized LOC121816785, transcript variant X3
uncharacterized LOC121816785, transcript variant X2
F-box and WD repeat domain containing 11, transcript variant X12
F-box and WD repeat domain containing 11, transcript variant X9
F-box and WD repeat domain containing 11, transcript variant X5
F-box and WD repeat domain containing 11, transcript variant X1
F-box and WD repeat domain containing 11, transcript variant X10
F-box and WD repeat domain containing 11, transcript variant X6
F-box and WD repeat domain containing 11, transcript variant X11
F-box and WD repeat domain containing 11, transcript variant X7
F-box and WD repeat domain containing 11, transcript variant X8
F-box and WD repeat domain containing 11, transcript variant X2
F-box and WD repeat domain containing 11, transcript variant X3
F-box and WD repeat domain containing 11, transcript variant X4
F-box/WD repeat-containing protein 11 isoform X6
F-box/WD repeat-containing protein 11 isoform X4
F-box/WD repeat-containing protein 11 isoform X2
F-box/WD repeat-containing protein 11 isoform X1
F-box/WD repeat-containing protein 11 isoform X3
F-box/WD repeat-containing protein 11 isoform X5
dual specificity protein phosphatase 8-like, transcript variant X1
dual specificity protein phosphatase 8-like
dual specificity protein phosphatase 8-like, transcript variant X2
EF-hand calcium-binding domain-containing protein 9
cytochrome c oxidase assembly factor 3 homolog, mitochondrial-like
SH3 and PX domains 2B, transcript variant X3
SH3 and PX domains 2B, transcript variant X1
SH3 and PX domains 2B, transcript variant X2
SH3 and PX domains 2B, transcript variant X4
SH3 and PX domain-containing protein 2B isoform X3
SH3 and PX domain-containing protein 2B isoform X1
SH3 and PX domain-containing protein 2B isoform X2
SH3 and PX domain-containing protein 2B isoform X4
neuralized E3 ubiquitin protein ligase 1B, transcript variant X1
neuralized E3 ubiquitin protein ligase 1B, transcript variant X2
E3 ubiquitin-protein ligase NEURL1B isoform X1
E3 ubiquitin-protein ligase NEURL1B isoform X2
endoplasmic reticulum-golgi intermediate compartment 1, transcript variant X1
endoplasmic reticulum-Golgi intermediate compartment protein 1 isoform X1
endoplasmic reticulum-golgi intermediate compartment 1, transcript variant X2
endoplasmic reticulum-Golgi intermediate compartment protein 1 isoform X2
endoplasmic reticulum-golgi intermediate compartment 1, transcript variant X3
endoplasmic reticulum-Golgi intermediate compartment protein 1 isoform X3
CREB3 regulatory factor, transcript variant X3
CREB3 regulatory factor, transcript variant X1
CREB3 regulatory factor, transcript variant X2
CREB3 regulatory factor, transcript variant X4
CREB3 regulatory factor, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
biorientation of chromosomes in cell division 1
biorientation of chromosomes in cell division protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
cytoplasmic polyadenylation element binding protein 4
cytoplasmic polyadenylation element-binding protein 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 53% coverage of the annotated genomic feature by RNAseq alignments
neuronal vesicle trafficking associated 2
neuronal vesicle trafficking-associated protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 41% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 14% coverage of the annotated genomic feature by RNAseq alignments
family with sequence similarity 169 member A, transcript variant X1
family with sequence similarity 169 member A, transcript variant X2
soluble lamin-associated protein of 75 kDa isoform X1
soluble lamin-associated protein of 75 kDa isoform X2
family with sequence similarity 169 member A, transcript variant X3
soluble lamin-associated protein of 75 kDa isoform X3
transfer RNA tryptophan (anticodon CCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
ribosome biogenesis protein NSA2 homolog
GTP dependent ribosome recycling factor mitochondrial 2, transcript variant X3
GTP dependent ribosome recycling factor mitochondrial 2, transcript variant X2
GTP dependent ribosome recycling factor mitochondrial 2, transcript variant X1
GTP dependent ribosome recycling factor mitochondrial 2, transcript variant X5
GTP dependent ribosome recycling factor mitochondrial 2, transcript variant X6
ribosome-releasing factor 2, mitochondrial isoform X1
ribosome-releasing factor 2, mitochondrial isoform X3
GTP dependent ribosome recycling factor mitochondrial 2, transcript variant X4
ribosome-releasing factor 2, mitochondrial isoform X2
beta-hexosaminidase subunit beta, transcript variant X2
beta-hexosaminidase subunit beta, transcript variant X1
beta-hexosaminidase subunit beta isoform X1
beta-hexosaminidase subunit beta isoform X2
beta-hexosaminidase subunit beta-like, transcript variant X1
beta-hexosaminidase subunit beta-like, transcript variant X2
beta-hexosaminidase subunit beta-like isoform X1
beta-hexosaminidase subunit beta-like isoform X2
transfer RNA arginine (anticodon UCG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Rho guanine nucleotide exchange factor 28, transcript variant X2
Rho guanine nucleotide exchange factor 28, transcript variant X5
Rho guanine nucleotide exchange factor 28, transcript variant X4
Rho guanine nucleotide exchange factor 28, transcript variant X7
Rho guanine nucleotide exchange factor 28, transcript variant X1
Rho guanine nucleotide exchange factor 28, transcript variant X3
Rho guanine nucleotide exchange factor 28, transcript variant X6
rho guanine nucleotide exchange factor 28 isoform X3
rho guanine nucleotide exchange factor 28 isoform X2
rho guanine nucleotide exchange factor 28 isoform X1
rho guanine nucleotide exchange factor 28 isoform X4
rho guanine nucleotide exchange factor 28 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 31% coverage of the annotated genomic feature by RNAseq alignments
UTP15 small subunit processome component
U3 small nucleolar RNA-associated protein 15 homolog
basic transcription factor 3, transcript variant X2
basic transcription factor 3, transcript variant X1
transmembrane protein 171, transcript variant X3
transmembrane protein 171, transcript variant X1
transmembrane protein 171, transcript variant X2
FCH and mu domain containing endocytic adaptor 2, transcript variant X1
FCH and mu domain containing endocytic adaptor 2, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
zinc finger protein 366, transcript variant X1
zinc finger protein 366, transcript variant X2
pentatricopeptide repeat domain 2, transcript variant X1
pentatricopeptide repeat domain 2, transcript variant X2
pentatricopeptide repeat domain 2, transcript variant X3
pentatricopeptide repeat-containing protein 2, mitochondrial isoform X1
pentatricopeptide repeat-containing protein 2, mitochondrial isoform X2
pentatricopeptide repeat-containing protein 2, mitochondrial isoform X3
28S ribosomal protein S27, mitochondrial
microtubule associated protein 1B, transcript variant X2
microtubule associated protein 1B, transcript variant X1
microtubule associated protein 1B, transcript variant X4
microtubule associated protein 1B, transcript variant X3
microtubule-associated protein 1B isoform X1
microtubule-associated protein 1B isoform X2
transfer RNA tyrosine (anticodon GUA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
cocaine- and amphetamine-regulated transcript protein
methylcrotonyl-CoA carboxylase subunit 2
methylcrotonoyl-CoA carboxylase beta chain, mitochondrial
peptidyl-prolyl cis-trans isomerase FKBP2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB, transcript variant X2
B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB, transcript variant X3
B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB, transcript variant X4
B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB, transcript variant X1
transcription factor TFIIIB component B'' homolog isoform X2
transcription factor TFIIIB component B'' homolog isoform X3
transcription factor TFIIIB component B'' homolog isoform X4
transcription factor TFIIIB component B'' homolog isoform X1
survival motor neuron protein, transcript variant X1
survival motor neuron protein, transcript variant X2
survival motor neuron protein, transcript variant X4
survival motor neuron protein, transcript variant X6
survival motor neuron protein, transcript variant X3
survival motor neuron protein, transcript variant X5
survival motor neuron protein isoform X1
survival motor neuron protein isoform X2
survival motor neuron protein isoform X3
survival motor neuron protein isoform X4
NLR family apoptosis inhibitory protein, transcript variant X3
NLR family apoptosis inhibitory protein, transcript variant X4
NLR family apoptosis inhibitory protein, transcript variant X2
NLR family apoptosis inhibitory protein, transcript variant X1
baculoviral IAP repeat-containing protein 1 isoform X3
baculoviral IAP repeat-containing protein 1 isoform X4
baculoviral IAP repeat-containing protein 1 isoform X2
baculoviral IAP repeat-containing protein 1 isoform X1
GTF2H2 family member C, transcript variant X2
GTF2H2 family member C, transcript variant X1
GTF2H2 family member C, transcript variant X3
general transcription factor IIH subunit 2-like protein
MARVEL domain containing 2, transcript variant X1
MARVEL domain containing 2, transcript variant X4
MARVEL domain containing 2, transcript variant X3
MARVEL domain containing 2, transcript variant X2
RAD17 checkpoint clamp loader component, transcript variant X5
RAD17 checkpoint clamp loader component, transcript variant X4
RAD17 checkpoint clamp loader component, transcript variant X2
RAD17 checkpoint clamp loader component, transcript variant X3
RAD17 checkpoint clamp loader component, transcript variant X1
RAD17 checkpoint clamp loader component, transcript variant X7
RAD17 checkpoint clamp loader component, transcript variant X6
cell cycle checkpoint protein RAD17 isoform X5
cell cycle checkpoint protein RAD17 isoform X4
cell cycle checkpoint protein RAD17 isoform X2
cell cycle checkpoint protein RAD17 isoform X3
cell cycle checkpoint protein RAD17 isoform X1
adenylate kinase 6; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to RNA sequence, mRNA (same species):RefSeq:NM_001285802.2
annotated by transcript or proteomic data
The RefSeq transcript has 2 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
TATA-box binding protein associated factor 9; Derived by automated computational analysis using gene prediction method: BestRefSeq.
TATA-box binding protein associated factor 9
similar to RNA sequence, mRNA (same species):RefSeq:NM_001285801.2
The RefSeq transcript has 1 substitution, 1 non-frameshifting indel compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to AA sequence (same species):RefSeq:NP_001272730.2
The RefSeq protein has 1 non-frameshifting indel compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
transcription initiation factor TFIID subunit 9
coiled-coil domain containing 125, transcript variant X1
coiled-coil domain containing 125, transcript variant X3
coiled-coil domain containing 125, transcript variant X4
coiled-coil domain containing 125, transcript variant X2
coiled-coil domain-containing protein 125 isoform X1
coiled-coil domain-containing protein 125 isoform X2
coiled-coil domain-containing protein 125 isoform X3
cyclin dependent kinase 7, transcript variant X1
cyclin dependent kinase 7, transcript variant X3
cyclin dependent kinase 7, transcript variant X2
28S ribosomal protein S36, mitochondrial
centromere protein H, transcript variant X2
centromere protein H, transcript variant X1
G2/mitotic-specific cyclin-B1 isoform X1
G2/mitotic-specific cyclin-B1 isoform X2
phosphoinositide-3-kinase regulatory subunit 1, transcript variant X3
phosphoinositide-3-kinase regulatory subunit 1, transcript variant X1
phosphoinositide-3-kinase regulatory subunit 1, transcript variant X2
phosphoinositide-3-kinase regulatory subunit 1, transcript variant X5
phosphoinositide-3-kinase regulatory subunit 1, transcript variant X4
phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1
phosphatidylinositol 3-kinase regulatory subunit alpha isoform X2
phosphatidylinositol 3-kinase regulatory subunit alpha isoform X4
phosphatidylinositol 3-kinase regulatory subunit alpha isoform X3
cytochrome c oxidase subunit 7B, mitochondrial-like
microtubule associated serine/threonine kinase family member 4, transcript variant X4
microtubule associated serine/threonine kinase family member 4, transcript variant X2
microtubule associated serine/threonine kinase family member 4, transcript variant X3
microtubule associated serine/threonine kinase family member 4, transcript variant X1
microtubule associated serine/threonine kinase family member 4, transcript variant X8
microtubule associated serine/threonine kinase family member 4, transcript variant X6
microtubule associated serine/threonine kinase family member 4, transcript variant X5
microtubule associated serine/threonine kinase family member 4, transcript variant X7
microtubule-associated serine/threonine-protein kinase 4 isoform X4
microtubule-associated serine/threonine-protein kinase 4 isoform X2
microtubule-associated serine/threonine-protein kinase 4 isoform X3
microtubule-associated serine/threonine-protein kinase 4 isoform X1
microtubule-associated serine/threonine-protein kinase 4 isoform X8
microtubule-associated serine/threonine-protein kinase 4 isoform X6
microtubule-associated serine/threonine-protein kinase 4 isoform X5
microtubule-associated serine/threonine-protein kinase 4 isoform X7
splicing regulatory glutamic acid and lysine rich protein 1, transcript variant X1
splicing regulatory glutamic acid and lysine rich protein 1, transcript variant X2
splicing regulatory glutamic acid and lysine rich protein 1, transcript variant X3
splicing regulatory glutamic acid and lysine rich protein 1, transcript variant X4
splicing regulatory glutamine/lysine-rich protein 1 isoform X1
splicing regulatory glutamine/lysine-rich protein 1 isoform X2
splicing regulatory glutamine/lysine-rich protein 1 isoform X3
erbb2 interacting protein, transcript variant X9
erbb2 interacting protein, transcript variant X2
erbb2 interacting protein, transcript variant X4
erbb2 interacting protein, transcript variant X12
erbb2 interacting protein, transcript variant X11
erbb2 interacting protein, transcript variant X10
erbb2 interacting protein, transcript variant X8
erbb2 interacting protein, transcript variant X6
erbb2 interacting protein, transcript variant X7
erbb2 interacting protein, transcript variant X5
erbb2 interacting protein, transcript variant X3
erbb2 interacting protein, transcript variant X1
small glutamine rich tetratricopeptide repeat co-chaperone beta, transcript variant X1
small glutamine rich tetratricopeptide repeat co-chaperone beta, transcript variant X2
small glutamine-rich tetratricopeptide repeat-containing protein beta isoform X1
small glutamine-rich tetratricopeptide repeat-containing protein beta isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 52% coverage of the annotated genomic feature by RNAseq alignments
trafficking protein particle complex subunit 13, transcript variant X4
trafficking protein particle complex subunit 13, transcript variant X3
trafficking protein particle complex subunit 13, transcript variant X2
trafficking protein particle complex subunit 13, transcript variant X1
trafficking protein particle complex subunit 13 isoform X4
trafficking protein particle complex subunit 13 isoform X3
trafficking protein particle complex subunit 13 isoform X2
trafficking protein particle complex subunit 13 isoform X1
tripartite motif containing 23, transcript variant X1
tripartite motif containing 23, transcript variant X2
E3 ubiquitin-protein ligase TRIM23 isoform X1
E3 ubiquitin-protein ligase TRIM23 isoform X2
tripartite motif containing 23, transcript variant X3
tripartite motif containing 23, transcript variant X5
tripartite motif containing 23, transcript variant X4
E3 ubiquitin-protein ligase TRIM23 isoform X3
peptidylprolyl isomerase domain and WD repeat containing 1
peptidylprolyl isomerase domain and WD repeat-containing protein 1
centromere protein K, transcript variant X3
centromere protein K, transcript variant X1
centromere protein K, transcript variant X5
centromere protein K, transcript variant X2
centromere protein K, transcript variant X6
centromere protein K, transcript variant X4
ADAM metallopeptidase with thrombospondin type 1 motif 6, transcript variant X2
ADAM metallopeptidase with thrombospondin type 1 motif 6, transcript variant X1
ADAM metallopeptidase with thrombospondin type 1 motif 6, transcript variant X5
ADAM metallopeptidase with thrombospondin type 1 motif 6, transcript variant X4
ADAM metallopeptidase with thrombospondin type 1 motif 6, transcript variant X3
ADAM metallopeptidase with thrombospondin type 1 motif 6, transcript variant X7
ADAM metallopeptidase with thrombospondin type 1 motif 6, transcript variant X6
ADAM metallopeptidase with thrombospondin type 1 motif 6, transcript variant X8
A disintegrin and metalloproteinase with thrombospondin motifs 6 isoform X1
A disintegrin and metalloproteinase with thrombospondin motifs 6 isoform X3
A disintegrin and metalloproteinase with thrombospondin motifs 6 isoform X2
A disintegrin and metalloproteinase with thrombospondin motifs 6 isoform X4
A disintegrin and metalloproteinase with thrombospondin motifs 6 isoform X5
uncharacterized LOC106990331, transcript variant X1
uncharacterized LOC106990331, transcript variant X4
uncharacterized LOC106990331, transcript variant X3
uncharacterized LOC106990331, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00015
CWC27 spliceosome associated cyclophilin, transcript variant X3
CWC27 spliceosome associated cyclophilin, transcript variant X4
CWC27 spliceosome associated cyclophilin, transcript variant X5
CWC27 spliceosome associated cyclophilin, transcript variant X2
CWC27 spliceosome associated cyclophilin, transcript variant X1
CWC27 spliceosome associated cyclophilin, transcript variant X9
CWC27 spliceosome associated cyclophilin, transcript variant X7
CWC27 spliceosome associated cyclophilin, transcript variant X6
spliceosome-associated protein CWC27 homolog isoform X2
spliceosome-associated protein CWC27 homolog isoform X1
spliceosome-associated protein CWC27 homolog isoform X4
CWC27 spliceosome associated cyclophilin, transcript variant X8
spliceosome-associated protein CWC27 homolog isoform X3
CWC27 spliceosome associated cyclophilin, transcript variant X10
spliceosome-associated protein CWC27 homolog isoform X5
SREK1 interacting protein 1, transcript variant X1
SREK1 interacting protein 1, transcript variant X2
SREK1 interacting protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
acidic leucine-rich nuclear phosphoprotein 32 family member B
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: acidic leucine-rich nuclear phosphoprotein 32 family member B
regulator of G protein signaling 7 binding protein
regulator of G-protein signaling 7-binding protein
transfer RNA glutamic acid (anticodon CUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glycine (anticodon CCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA serine (anticodon GGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
ring finger protein 180, transcript variant X2
ring finger protein 180, transcript variant X3
ring finger protein 180, transcript variant X1
E3 ubiquitin-protein ligase RNF180 isoform X2
E3 ubiquitin-protein ligase RNF180 isoform X3
E3 ubiquitin-protein ligase RNF180 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 long SRA reads, 15 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
leucine-rich repeat-containing protein 70
DIM1 rRNA methyltransferase and ribosome maturation factor
kinesin family member 2A, transcript variant X7
kinesin family member 2A, transcript variant X4
kinesin family member 2A, transcript variant X3
kinesin family member 2A, transcript variant X6
kinesin family member 2A, transcript variant X2
kinesin family member 2A, transcript variant X5
kinesin family member 2A, transcript variant X1
zinc finger SWIM domain-containing protein 6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
small integral membrane protein 15, transcript variant X2
small integral membrane protein 15, transcript variant X1
small integral membrane protein 15 isoform X1
small integral membrane protein 15, transcript variant X3
small integral membrane protein 15 isoform X2
NADH:ubiquinone oxidoreductase complex assembly factor 2
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 37% coverage of the annotated genomic feature by RNAseq alignments
ERCC excision repair 8, CSA ubiquitin ligase complex subunit, transcript variant X1
ERCC excision repair 8, CSA ubiquitin ligase complex subunit, transcript variant X2
DNA excision repair protein ERCC-8 isoform X1
DNA excision repair protein ERCC-8 isoform X2
ELOVL fatty acid elongase 7, transcript variant X1
ELOVL fatty acid elongase 7, transcript variant X2
elongation of very long chain fatty acids protein 7 isoform X1
elongation of very long chain fatty acids protein 7 isoform X2
phosphodiesterase 4D, transcript variant X3
phosphodiesterase 4D, transcript variant X4
phosphodiesterase 4D, transcript variant X2
cAMP-specific 3',5'-cyclic phosphodiesterase 4D isoform X2
phosphodiesterase 4D, transcript variant X5
cAMP-specific 3',5'-cyclic phosphodiesterase 4D isoform X3
phosphodiesterase 4D, transcript variant X7
phosphodiesterase 4D, transcript variant X8
cAMP-specific 3',5'-cyclic phosphodiesterase 4D isoform X5
transfer RNA histidin (anticodon AUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
phosphodiesterase 4D, transcript variant X1
cAMP-specific 3',5'-cyclic phosphodiesterase 4D isoform X1
phosphodiesterase 4D, transcript variant X6
cAMP-specific 3',5'-cyclic phosphodiesterase 4D isoform X4
phosphodiesterase 4D, transcript variant X10
cAMP-specific 3',5'-cyclic phosphodiesterase 4D isoform X7
phosphodiesterase 4D, transcript variant X9
cAMP-specific 3',5'-cyclic phosphodiesterase 4D isoform X6
RAB3C, member RAS oncogene family, transcript variant X2
RAB3C, member RAS oncogene family, transcript variant X1
GRB2 binding adaptor protein, transmembrane, transcript variant X2
GRB2 binding adaptor protein, transmembrane, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 422 Proteins, and 34% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 39% coverage of the annotated genomic feature by RNAseq alignments
GC-rich promoter binding protein 1, transcript variant X4
GC-rich promoter binding protein 1, transcript variant X1
GC-rich promoter binding protein 1, transcript variant X5
GC-rich promoter binding protein 1, transcript variant X2
GC-rich promoter binding protein 1, transcript variant X3
MIER family member 3, transcript variant X4
MIER family member 3, transcript variant X5
MIER family member 3, transcript variant X1
MIER family member 3, transcript variant X2
mesoderm induction early response protein 3 isoform X1
mesoderm induction early response protein 3 isoform X2
MIER family member 3, transcript variant X3
mesoderm induction early response protein 3 isoform X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
mitogen-activated protein kinase kinase kinase 1, transcript variant X1
mitogen-activated protein kinase kinase kinase 1, transcript variant X3
mitogen-activated protein kinase kinase kinase 1, transcript variant X2
mitogen-activated protein kinase kinase kinase 1 isoform X1
mitogen-activated protein kinase kinase kinase 1 isoform X2
mitogen-activated protein kinase kinase kinase 1 isoform X3
mitogen-activated protein kinase kinase kinase 1, transcript variant X4
mitogen-activated protein kinase kinase kinase 1 isoform X4
uncharacterized LOC121816803, transcript variant X2
uncharacterized LOC121816803, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC121816803, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
ankyrin repeat domain 55, transcript variant X3
ankyrin repeat domain 55, transcript variant X1
ankyrin repeat domain 55, transcript variant X5
ankyrin repeat domain 55, transcript variant X4
ankyrin repeat domain 55, transcript variant X2
ankyrin repeat domain-containing protein 55 isoform X1
ankyrin repeat domain-containing protein 55 isoform X3
ankyrin repeat domain-containing protein 55 isoform X2
interleukin 6 cytokine family signal transducer
28S ribosomal protein S18c, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
DEAD-box helicase 4, transcript variant X2
DEAD-box helicase 4, transcript variant X1
probable ATP-dependent RNA helicase DDX4 isoform X2
probable ATP-dependent RNA helicase DDX4 isoform X1
solute carrier family 38 member 9, transcript variant X3
solute carrier family 38 member 9, transcript variant X4
solute carrier family 38 member 9, transcript variant X2
solute carrier family 38 member 9, transcript variant X1
solute carrier family 38 member 9, transcript variant X6
sodium-coupled neutral amino acid transporter 9 isoform X1
solute carrier family 38 member 9, transcript variant X5
sodium-coupled neutral amino acid transporter 9 isoform X2
phospholipid phosphatase 1, transcript variant X1
phospholipid phosphatase 1, transcript variant X2
phospholipid phosphatase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
DExH-box helicase 29, transcript variant X2
DExH-box helicase 29, transcript variant X1
DExH-box helicase 29, transcript variant X3
multiciliate differentiation and DNA synthesis associated cell cycle protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 3 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
cell division cycle protein 20 homolog B
glutathione peroxidase 8 (putative), transcript variant X2
glutathione peroxidase 8 (putative), transcript variant X1
probable glutathione peroxidase 8 isoform X1
probable glutathione peroxidase 8 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 253 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
chondroitin sulfate proteoglycan 4-like, transcript variant X1
chondroitin sulfate proteoglycan 4-like, transcript variant X2
chondroitin sulfate proteoglycan 4-like isoform X2
chondroitin sulfate proteoglycan 4-like isoform X1
chondroitin sulfate proteoglycan 4-like, transcript variant X3
chondroitin sulfate proteoglycan 4-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
heat shock protein family B (small) member 3, transcript variant X1
heat shock protein family B (small) member 3, transcript variant X2
transfer RNA alanine (anticodon GGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC121816807, transcript variant X1
uncharacterized LOC121816807, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
NADH:ubiquinone oxidoreductase subunit S4
NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial
follistatin; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
similar to RNA sequence, mRNA (same species):RefSeq:NM_001257093.1
The RefSeq transcript has 4 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to AA sequence (same species):RefSeq:NP_001244022.1
The RefSeq protein has 3 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
COORDINATES: ab initio prediction:SignalP:4.0
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 50% coverage of the annotated genomic feature by RNAseq alignments
molybdenum cofactor synthesis 2, transcript variant X3
molybdenum cofactor synthesis 2, transcript variant X5
molybdenum cofactor synthesis 2, transcript variant X1
molybdenum cofactor synthesis 2, transcript variant X4
molybdopterin synthase catalytic subunit isoform X1
molybdopterin synthase sulfur carrier subunit isoform X4
molybdenum cofactor synthesis 2, transcript variant X2
molybdopterin synthase catalytic subunit isoform X2
molybdopterin synthase catalytic subunit isoform X3
molybdopterin synthase catalytic subunit isoform X5
integrin subunit alpha 1, transcript variant X1
integrin subunit alpha 1, transcript variant X2
pelota mRNA surveillance and ribosome rescue factor, transcript variant X4
pelota mRNA surveillance and ribosome rescue factor, transcript variant X3
pelota mRNA surveillance and ribosome rescue factor, transcript variant X2
pelota mRNA surveillance and ribosome rescue factor, transcript variant X1
poly(ADP-ribose) polymerase family member 8, transcript variant X3
poly(ADP-ribose) polymerase family member 8, transcript variant X1
poly(ADP-ribose) polymerase family member 8, transcript variant X2
protein mono-ADP-ribosyltransferase PARP8 isoform X3
protein mono-ADP-ribosyltransferase PARP8 isoform X1
protein mono-ADP-ribosyltransferase PARP8 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 71% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 14% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
hyperpolarization activated cyclic nucleotide gated potassium channel 1
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1
39S ribosomal protein S30, mitochondrial
fibroblast growth factor 10; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to RNA sequence, mRNA (same species):RefSeq:NM_001009230.1
The RefSeq transcript has 5 substitutions, 5 non-frameshifting indels compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
nicotinamide nucleotide transhydrogenase, transcript variant X2
nicotinamide nucleotide transhydrogenase, transcript variant X3
nicotinamide nucleotide transhydrogenase, transcript variant X4
nicotinamide nucleotide transhydrogenase, transcript variant X5
nicotinamide nucleotide transhydrogenase, transcript variant X1
transfer RNA cysteine (anticodon ACA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
poly(A) binding protein interacting protein 1, transcript variant X3
poly(A) binding protein interacting protein 1, transcript variant X4
poly(A) binding protein interacting protein 1, transcript variant X1
poly(A) binding protein interacting protein 1, transcript variant X2
polyadenylate-binding protein-interacting protein 1 isoform X1
polyadenylate-binding protein-interacting protein 1 isoform X2
polyadenylate-binding protein-interacting protein 1 isoform X3
chromosome 16 C5orf34 homolog, transcript variant X6
chromosome 16 C5orf34 homolog, transcript variant X4
chromosome 16 C5orf34 homolog, transcript variant X5
chromosome 16 C5orf34 homolog, transcript variant X1
chromosome 16 C5orf34 homolog, transcript variant X8
chromosome 16 C5orf34 homolog, transcript variant X2
chromosome 16 C5orf34 homolog, transcript variant X7
chromosome 16 C5orf34 homolog, transcript variant X9
chromosome 16 C5orf34 homolog, transcript variant X3
chromosome 16 C5orf34 homolog, transcript variant X10
chromosome 16 C5orf34 homolog, transcript variant X11
uncharacterized protein C5orf34 homolog isoform X1
uncharacterized protein C5orf34 homolog isoform X2
transmembrane protein 267, transcript variant X3
transmembrane protein 267, transcript variant X4
transmembrane protein 267, transcript variant X2
transmembrane protein 267, transcript variant X1
transmembrane protein 267, transcript variant X5
C-C motif chemokine ligand 28; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to RNA sequence, mRNA (same species):RefSeq:NM_001129903.1
The RefSeq transcript has 2 substitutions, 2 non-frameshifting indels compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
3-hydroxy-3-methylglutaryl-CoA synthase 1, transcript variant X1
3-hydroxy-3-methylglutaryl-CoA synthase 1, transcript variant X3
3-hydroxy-3-methylglutaryl-CoA synthase 1, transcript variant X2
hydroxymethylglutaryl-CoA synthase, cytoplasmic isoform X1
hydroxymethylglutaryl-CoA synthase, cytoplasmic isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
zinc finger protein 131, transcript variant X5
zinc finger protein 131, transcript variant X6
zinc finger protein 131, transcript variant X1
zinc finger protein 131, transcript variant X4
zinc finger protein 131, transcript variant X8
zinc finger protein 131, transcript variant X3
zinc finger protein 131, transcript variant X7
zinc finger protein 131, transcript variant X2
zinc finger protein 131, transcript variant X9
zinc finger protein 131, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 48% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 36% coverage of the annotated genomic feature by RNAseq alignments
coiled-coil domain-containing protein 152
growth hormone receptor; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
growth hormone receptor, transcript variant X4
growth hormone receptor, transcript variant X2
growth hormone receptor, transcript variant X3
growth hormone receptor, transcript variant X1
similar to RNA sequence, mRNA (same species):RefSeq:NM_001009323.2
N-linked (GlcNAc...) asparagine. /evidence=ECO:0000255; propagated from UniProtKB/Swiss-Prot (Q28575.1); glycosylation site
propagated from UniProtKB/Swiss-Prot (Q28575.1); Region: WSXWS motif
propagated from UniProtKB/Swiss-Prot (Q28575.1); transmembrane region
propagated from UniProtKB/Swiss-Prot (Q28575.1); Region: Required for JAK2 binding. /evidence=ECO:0000250
propagated from UniProtKB/Swiss-Prot (Q28575.1); Region: Box 1 motif
propagated from UniProtKB/Swiss-Prot (Q28575.1); Region: UbE motif
Phosphoserine. /evidence=ECO:0000250|UniProtKB:P10912; propagated from UniProtKB/Swiss-Prot (Q28575.1); phosphorylation site
Required for endocytosis and down-regulation. /evidence=ECO:0000250; propagated from UniProtKB/Swiss-Prot (Q28575.1); other site
propagated from UniProtKB/Swiss-Prot (Q28575.1); Region: Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite
uncharacterized LOC114118741, transcript variant X1
uncharacterized LOC114118741, transcript variant X2
chromosome 16 C5orf51 homolog, transcript variant X2
chromosome 16 C5orf51 homolog, transcript variant X1
UPF0600 protein C5orf51 homolog isoform X2
UPF0600 protein C5orf51 homolog isoform X1
3-oxoacid CoA-transferase 1, transcript variant X1
succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial isoform X1
3-oxoacid CoA-transferase 1, transcript variant X2
succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial isoform X2
phosphatidylinositol specific phospholipase C X domain containing 3
maestro heat like repeat family member 2B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 37% coverage of the annotated genomic feature by RNAseq alignments
maestro heat-like repeat-containing protein family member 2B
caspase recruitment domain family member 6, transcript variant X2
caspase recruitment domain family member 6, transcript variant X1
caspase recruitment domain-containing protein 6 isoform X2
caspase recruitment domain-containing protein 6 isoform X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00577
protein kinase AMP-activated catalytic subunit alpha 1, transcript variant X6
protein kinase AMP-activated catalytic subunit alpha 1, transcript variant X1
5'-AMP-activated protein kinase catalytic subunit alpha-1 isoform X4
5'-AMP-activated protein kinase catalytic subunit alpha-1 isoform X1
protein kinase AMP-activated catalytic subunit alpha 1, transcript variant X4
protein kinase AMP-activated catalytic subunit alpha 1, transcript variant X3
protein kinase AMP-activated catalytic subunit alpha 1, transcript variant X2
protein kinase AMP-activated catalytic subunit alpha 1, transcript variant X5
5'-AMP-activated protein kinase catalytic subunit alpha-1 isoform X2
5'-AMP-activated protein kinase catalytic subunit alpha-1 isoform X3
tetratricopeptide repeat domain 33, transcript variant X4
tetratricopeptide repeat domain 33, transcript variant X2
tetratricopeptide repeat domain 33, transcript variant X3
tetratricopeptide repeat domain 33, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 38% coverage of the annotated genomic feature by RNAseq alignments
DAB adaptor protein 2, transcript variant X2
DAB adaptor protein 2, transcript variant X1
DAB adaptor protein 2, transcript variant X3
DAB adaptor protein 2, transcript variant X5
DAB adaptor protein 2, transcript variant X4
DAB adaptor protein 2, transcript variant X6
FYN binding protein 1, transcript variant X5
FYN binding protein 1, transcript variant X1
FYN binding protein 1, transcript variant X3
FYN binding protein 1, transcript variant X4
FYN binding protein 1, transcript variant X2
RPTOR independent companion of MTOR complex 2, transcript variant X1
RPTOR independent companion of MTOR complex 2, transcript variant X2
rapamycin-insensitive companion of mTOR isoform X1
rapamycin-insensitive companion of mTOR isoform X2
oncostatin M receptor, transcript variant X1
oncostatin-M-specific receptor subunit beta
oncostatin M receptor, transcript variant X2
ubiquitin-fold modifier-conjugating enzyme 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC114118742, transcript variant X3
uncharacterized LOC114118742, transcript variant X2
uncharacterized LOC114118742, transcript variant X1
uncharacterized LOC114118743, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC114118743, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
LIF receptor subunit alpha, transcript variant X1
LIF receptor subunit alpha, transcript variant X2
EGF like, fibronectin type III and laminin G domains
uncharacterized LOC106991666, transcript variant X2
uncharacterized LOC106991666, transcript variant X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00416
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
WD repeat domain 70, transcript variant X2
WD repeat domain 70, transcript variant X1
WD repeat domain 70, transcript variant X3
WD repeat-containing protein 70 isoform X1
WD repeat-containing protein 70 isoform X2
WD repeat-containing protein 70 isoform X3
nuclear pore complex protein Nup155 isoform X1
nuclear pore complex protein Nup155 isoform X2
ciliogenesis and planar polarity effector 1, transcript variant X1
ciliogenesis and planar polarity effector 1, transcript variant X12
ciliogenesis and planar polarity effector 1, transcript variant X6
ciliogenesis and planar polarity effector 1, transcript variant X2
ciliogenesis and planar polarity effector 1, transcript variant X7
ciliogenesis and planar polarity effector 1, transcript variant X8
ciliogenesis and planar polarity effector 1, transcript variant X5
ciliogenesis and planar polarity effector 1, transcript variant X9
ciliogenesis and planar polarity effector 1, transcript variant X3
ciliogenesis and planar polarity effector 1, transcript variant X4
ciliogenesis and planar polarity effector 1, transcript variant X10
ciliogenesis and planar polarity effector 1, transcript variant X11
ciliogenesis and planar polarity effector 1, transcript variant X14
ciliogenesis and planar polarity effector 1, transcript variant X13
ciliogenesis and planar polarity effector 1, transcript variant X15
ciliogenesis and planar polarity effector 1, transcript variant X16
ciliogenesis and planar polarity effector 1, transcript variant X17
ciliogenesis and planar polarity effector 1, transcript variant X18
ciliogenesis and planar polarity effector 1 isoform X1
ciliogenesis and planar polarity effector 1 isoform X6
ciliogenesis and planar polarity effector 1 isoform X2
ciliogenesis and planar polarity effector 1 isoform X7
ciliogenesis and planar polarity effector 1 isoform X8
ciliogenesis and planar polarity effector 1 isoform X5
ciliogenesis and planar polarity effector 1 isoform X9
ciliogenesis and planar polarity effector 1 isoform X3
ciliogenesis and planar polarity effector 1 isoform X4
ciliogenesis and planar polarity effector 1 isoform X17
ciliogenesis and planar polarity effector 1 isoform X10
ciliogenesis and planar polarity effector 1 isoform X11
ciliogenesis and planar polarity effector 1 isoform X13
ciliogenesis and planar polarity effector 1 isoform X12
ciliogenesis and planar polarity effector 1 isoform X14
ciliogenesis and planar polarity effector 1 isoform X15
ciliogenesis and planar polarity effector 1 isoform X16
NIPBL cohesin loading factor, transcript variant X3
NIPBL cohesin loading factor, transcript variant X5
NIPBL cohesin loading factor, transcript variant X1
NIPBL cohesin loading factor, transcript variant X4
NIPBL cohesin loading factor, transcript variant X2
solute carrier family 1 member 3, transcript variant X1
solute carrier family 1 member 3, transcript variant X2
excitatory amino acid transporter 1 isoform X1
excitatory amino acid transporter 1 isoform X2
RAN binding protein 3 like, transcript variant X1
RAN binding protein 3 like, transcript variant X3
RAN binding protein 3 like, transcript variant X2
RAN binding protein 3 like, transcript variant X4
RAN binding protein 3 like, transcript variant X6
RAN binding protein 3 like, transcript variant X5
NAD kinase 2, mitochondrial, transcript variant X1
NAD kinase 2, mitochondrial, transcript variant X2
NAD kinase 2, mitochondrial, transcript variant X3
S-phase kinase associated protein 2, transcript variant X2
S-phase kinase associated protein 2, transcript variant X1
S-phase kinase associated protein 2, transcript variant X3
S-phase kinase-associated protein 2 isoform X2
S-phase kinase-associated protein 2 isoform X1
S-phase kinase-associated protein 2 isoform X3
S-phase kinase associated protein 2, transcript variant X4
S-phase kinase-associated protein 2 isoform X4
LMBR1 domain containing 2, transcript variant X1
LMBR1 domain containing 2, transcript variant X4
LMBR1 domain containing 2, transcript variant X5
LMBR1 domain containing 2, transcript variant X2
LMBR1 domain containing 2, transcript variant X6
LMBR1 domain containing 2, transcript variant X3
G-protein coupled receptor-associated protein LMBRD2 isoform X3
G-protein coupled receptor-associated protein LMBRD2 isoform X1
G-protein coupled receptor-associated protein LMBRD2 isoform X2
G-protein coupled receptor-associated protein LMBRD2 isoform X4
UDP-glucuronosyltransferase 3A1, transcript variant X1
UDP-glucuronosyltransferase 3A1 isoform X1
UDP-glucuronosyltransferase 3A1, transcript variant X2
UDP-glucuronosyltransferase 3A1 isoform X2
UDP-glucuronosyltransferase 3A1-like, transcript variant X1
UDP-glucuronosyltransferase 3A1-like, transcript variant X2
UDP-glucuronosyltransferase 3A1-like isoform X1
UDP-glucuronosyltransferase 3A1-like isoform X2
calcyphosine like, transcript variant X2
calcyphosine like, transcript variant X3
calcyphosine like, transcript variant X7
calcyphosine like, transcript variant X5
calcyphosine like, transcript variant X9
calcyphosine like, transcript variant X8
calcyphosine like, transcript variant X4
calcyphosine like, transcript variant X1
calcyphosine like, transcript variant X6
interleukin 7 receptor, transcript variant X8
interleukin 7 receptor, transcript variant X5
interleukin 7 receptor, transcript variant X6
interleukin 7 receptor, transcript variant X7
interleukin 7 receptor, transcript variant X4
interleukin 7 receptor, transcript variant X3
interleukin 7 receptor, transcript variant X1
interleukin 7 receptor, transcript variant X2
interleukin-7 receptor subunit alpha isoform X3
interleukin-7 receptor subunit alpha isoform X1
interleukin-7 receptor subunit alpha isoform X2
interleukin-7 receptor subunit alpha isoform X4
interleukin-7 receptor subunit alpha isoform X5
sperm flagellar 2, transcript variant X7
sperm flagellar 2, transcript variant X11
sperm flagellar 2, transcript variant X6
sperm flagellar 2, transcript variant X9
sperm flagellar 2, transcript variant X5
sperm flagellar 2, transcript variant X10
sperm flagellar 2, transcript variant X12
sperm flagellar 2, transcript variant X4
sperm flagellar 2, transcript variant X2
sperm flagellar 2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
sperm flagellar 2, transcript variant X3
sperm flagellar 2, transcript variant X1
prolactin receptor; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to RNA sequence, mRNA (same species):RefSeq:NM_001009204.1
The RefSeq transcript has 2 frameshifts compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to AA sequence (same species):RefSeq:NP_001009204.1
The RefSeq protein has 2 frameshifts compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
alanine--glyoxylate aminotransferase 2, transcript variant X2
alanine--glyoxylate aminotransferase 2, transcript variant X1
alanine--glyoxylate aminotransferase 2, transcript variant X4
alanine--glyoxylate aminotransferase 2, transcript variant X3
alanine--glyoxylate aminotransferase 2, mitochondrial isoform X1
alanine--glyoxylate aminotransferase 2, mitochondrial isoform X4
alanine--glyoxylate aminotransferase 2, mitochondrial isoform X2
alanine--glyoxylate aminotransferase 2, mitochondrial isoform X3
DnaJ heat shock protein family (Hsp40) member C21, transcript variant X1
DnaJ heat shock protein family (Hsp40) member C21, transcript variant X2
dnaJ homolog subfamily C member 21 isoform X1
dnaJ homolog subfamily C member 21 isoform X2
ribosome biogenesis protein BRX1 homolog
RAD1 checkpoint DNA exonuclease, transcript variant X1
cell cycle checkpoint protein RAD1 isoform X1
RAD1 checkpoint DNA exonuclease, transcript variant X2
cell cycle checkpoint protein RAD1 isoform X2
tetratricopeptide repeat domain 23 like, transcript variant X2
tetratricopeptide repeat domain 23 like, transcript variant X1
tetratricopeptide repeat protein 23-like
retinoic acid induced 14, transcript variant X14
retinoic acid induced 14, transcript variant X3
retinoic acid induced 14, transcript variant X6
retinoic acid induced 14, transcript variant X11
retinoic acid induced 14, transcript variant X5
retinoic acid induced 14, transcript variant X8
retinoic acid induced 14, transcript variant X12
retinoic acid induced 14, transcript variant X10
retinoic acid induced 14, transcript variant X7
retinoic acid induced 14, transcript variant X9
retinoic acid induced 14, transcript variant X4
retinoic acid induced 14, transcript variant X13
retinoic acid induced 14, transcript variant X2
retinoic acid induced 14, transcript variant X1
C1q and TNF related 3, transcript variant X1
C1q and TNF related 3, transcript variant X2
C1q and TNF related 3, transcript variant X3
complement C1q tumor necrosis factor-related protein 3 isoform X1
complement C1q tumor necrosis factor-related protein 3 isoform X2
complement C1q tumor necrosis factor-related protein 3 isoform X3
ADAM metallopeptidase with thrombospondin type 1 motif 12
A disintegrin and metalloproteinase with thrombospondin motifs 12
transfer RNA threonine (anticodon UGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
natriuretic peptide receptor 3, transcript variant X2
natriuretic peptide receptor 3, transcript variant X1
atrial natriuretic peptide receptor 3 isoform X2
atrial natriuretic peptide receptor 3 isoform X1
SUB1 regulator of transcription, transcript variant X2
SUB1 regulator of transcription, transcript variant X1
activated RNA polymerase II transcriptional coactivator p15
zinc finger RNA binding protein, transcript variant X1
zinc finger RNA binding protein, transcript variant X2
zinc finger RNA binding protein, transcript variant X3
zinc finger RNA-binding protein isoform X1
zinc finger RNA-binding protein isoform X2
zinc finger RNA-binding protein isoform X3
PDZ domain containing 2, transcript variant X2
PDZ domain containing 2, transcript variant X1
PDZ domain containing 2, transcript variant X3
PDZ domain containing 2, transcript variant X4
PDZ domain-containing protein 2 isoform X2
PDZ domain-containing protein 2 isoform X1
PDZ domain-containing protein 2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 45% coverage of the annotated genomic feature by RNAseq alignments
drosha ribonuclease III, transcript variant X1
drosha ribonuclease III, transcript variant X2
drosha ribonuclease III, transcript variant X4
drosha ribonuclease III, transcript variant X3
succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 29% coverage of the annotated genomic feature by RNAseq alignments
peptidyl-prolyl cis-trans isomerase FKBP3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 35% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 12 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: serine/threonine-protein kinase NLK
transfer RNA phenylalanine (anticodon GAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 13% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA glycine (anticodon GCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 53% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 30% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA serine (anticodon GCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 22% coverage of the annotated genomic feature by RNAseq alignments
transcription initiation factor TFIID subunit 11-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins
brain abundant membrane attached signal protein 1, transcript variant X1
brain abundant membrane attached signal protein 1, transcript variant X4
brain abundant membrane attached signal protein 1, transcript variant X2
brain abundant membrane attached signal protein 1, transcript variant X3
uncharacterized LOC114118751, transcript variant X3
uncharacterized LOC114118751, transcript variant X1
uncharacterized LOC114118751, transcript variant X2
reticulophagy regulator 1, transcript variant X1
reticulophagy regulator 1, transcript variant X2
membrane associated ring-CH-type finger 11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins
ANKH inorganic pyrophosphate transport regulator
OTU deubiquitinase with linear linkage specificity, transcript variant X5
OTU deubiquitinase with linear linkage specificity, transcript variant X4
OTU deubiquitinase with linear linkage specificity, transcript variant X2
OTU deubiquitinase with linear linkage specificity, transcript variant X1
OTU deubiquitinase with linear linkage specificity, transcript variant X3
ubiquitin thioesterase otulin isoform X5
ubiquitin thioesterase otulin isoform X4
ubiquitin thioesterase otulin isoform X2
ubiquitin thioesterase otulin isoform X1
ubiquitin thioesterase otulin isoform X3
OTU deubiquitinase with linear linkage specificity like, transcript variant X2
OTU deubiquitinase with linear linkage specificity like, transcript variant X1
inactive ubiquitin thioesterase OTULINL isoform X2
inactive ubiquitin thioesterase OTULINL isoform X1
trio Rho guanine nucleotide exchange factor
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: triple functional domain protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 25% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 23% coverage of the annotated genomic feature by RNAseq alignments
developmental pluripotency-associated protein 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 38% coverage of the annotated genomic feature by RNAseq alignments
ribosyldihydronicotinamide dehydrogenase [quinone]-like
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: ribosyldihydronicotinamide dehydrogenase [quinone]-like
ankyrin repeat domain 33B, transcript variant X2
ankyrin repeat domain 33B, transcript variant X1
ankyrin repeat domain-containing protein 33B isoform X2
ankyrin repeat domain-containing protein 33B isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 85% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
rhophilin associated tail protein 1 like
membrane associated ring-CH-type finger 6, transcript variant X2
membrane associated ring-CH-type finger 6, transcript variant X1
E3 ubiquitin-protein ligase MARCHF6 isoform X2
E3 ubiquitin-protein ligase MARCHF6 isoform X1
carboxymethylenebutenolidase homolog, transcript variant X1
carboxymethylenebutenolidase homolog, transcript variant X2
ATP synthase c subunit lysine N-methyltransferase, transcript variant X1
ATP synthase c subunit lysine N-methyltransferase, transcript variant X3
ATP synthase c subunit lysine N-methyltransferase, transcript variant X2
ATP synthase c subunit lysine N-methyltransferase, transcript variant X4
ATP synthase c subunit lysine N-methyltransferase, transcript variant X5
ATP synthase subunit C lysine N-methyltransferase isoform X1
ATP synthase subunit C lysine N-methyltransferase isoform X2
ATP synthase subunit C lysine N-methyltransferase isoform X3
ATP synthase c subunit lysine N-methyltransferase, transcript variant X6
ATP synthase c subunit lysine N-methyltransferase, transcript variant X7
ATP synthase subunit C lysine N-methyltransferase isoform X4
COORDINATES: nucleotide motif:Rfam:12.0:RF01156
transfer RNA arginine (anticodon GCG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
5-methyltetrahydrofolate-homocysteine methyltransferase reductase, transcript variant X6
5-methyltetrahydrofolate-homocysteine methyltransferase reductase, transcript variant X5
5-methyltetrahydrofolate-homocysteine methyltransferase reductase, transcript variant X2
5-methyltetrahydrofolate-homocysteine methyltransferase reductase, transcript variant X4
5-methyltetrahydrofolate-homocysteine methyltransferase reductase, transcript variant X1
5-methyltetrahydrofolate-homocysteine methyltransferase reductase, transcript variant X3
methionine synthase reductase isoform X3
methionine synthase reductase isoform X2
methionine synthase reductase isoform X1
FAST kinase domains 3, transcript variant X3
FAST kinase domains 3, transcript variant X1
FAST kinase domains 3, transcript variant X4
FAST kinase domains 3, transcript variant X2
FAST kinase domain-containing protein 3, mitochondrial
uncharacterized LOC105602640, transcript variant X1
uncharacterized LOC105602640, transcript variant X2
terminal nucleotidyltransferase 4A, transcript variant X2
terminal nucleotidyltransferase 4A, transcript variant X1
terminal nucleotidyltransferase 4A isoform X2
terminal nucleotidyltransferase 4A isoform X1
NOP2/Sun RNA methyltransferase 2, transcript variant X1
NOP2/Sun RNA methyltransferase 2, transcript variant X2
RNA cytosine C(5)-methyltransferase NSUN2 isoform X1
RNA cytosine C(5)-methyltransferase NSUN2 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00156
ubiquitin conjugating enzyme E2 Q family like 1
ubiquitin-conjugating enzyme E2Q-like protein 1
mediator of RNA polymerase II transcription subunit 10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
interactor of little elongation complex ELL subunit 1, transcript variant X2
interactor of little elongation complex ELL subunit 1, transcript variant X1
little elongation complex subunit 1 isoform X2
little elongation complex subunit 1 isoform X1
interactor of little elongation complex ELL subunit 1, transcript variant X3
little elongation complex subunit 1 isoform X3
uncharacterized LOC105602647, transcript variant X2
uncharacterized LOC105602647, transcript variant X1
uncharacterized LOC105602647, transcript variant X3
ADAM metallopeptidase with thrombospondin type 1 motif 16
A disintegrin and metalloproteinase with thrombospondin motifs 16
iroquois-class homeodomain protein IRX-1
uncharacterized LOC121816827, transcript variant X4
uncharacterized LOC121816827, transcript variant X7
uncharacterized LOC121816827, transcript variant X2
uncharacterized LOC121816827, transcript variant X5
uncharacterized LOC121816827, transcript variant X1
uncharacterized LOC121816827, transcript variant X3
uncharacterized LOC121816827, transcript variant X6
iroquois homeobox 2, transcript variant X3
iroquois homeobox 2, transcript variant X2
iroquois homeobox 2, transcript variant X1
iroquois-class homeodomain protein IRX-2 isoform X1
iroquois-class homeodomain protein IRX-2 isoform X2
iroquois-class homeodomain protein IRX-4
uncharacterized LOC121816828, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
uncharacterized LOC121816828, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
NADH:ubiquinone oxidoreductase subunit S6, transcript variant X1
NADH:ubiquinone oxidoreductase subunit S6, transcript variant X3
NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial isoform X1
NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial isoform X3
NADH:ubiquinone oxidoreductase subunit S6, transcript variant X2
NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial isoform X2
39S ribosomal protein L36, mitochondrial
uncharacterized LOC121816830, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 6 long SRA reads, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC121816830, transcript variant X1
uncharacterized LOC121816830, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
lysophosphatidylcholine acyltransferase 1, transcript variant X1
lysophosphatidylcholine acyltransferase 1, transcript variant X2
lysophosphatidylcholine acyltransferase 1 isoform X1
lysophosphatidylcholine acyltransferase 1 isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 3 bases in 3 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 3 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: sodium-dependent dopamine transporter
cleft lip and palate transmembrane protein 1-like protein isoform X3
cleft lip and palate transmembrane protein 1-like protein isoform X4
cleft lip and palate transmembrane protein 1-like protein isoform X1
cleft lip and palate transmembrane protein 1-like protein isoform X2
telomerase reverse transcriptase, transcript variant X1
telomerase reverse transcriptase, transcript variant X2
telomerase reverse transcriptase, transcript variant X3
telomerase reverse transcriptase isoform X1
telomerase reverse transcriptase isoform X3
telomerase reverse transcriptase isoform X2
inactive sodium-dependent neutral amino acid transporter B(0)AT3
sodium-dependent neutral amino acid transporter B(0)AT1
solute carrier family 12 member 7, transcript variant X1
solute carrier family 12 member 7, transcript variant X2
solute carrier family 12 member 7, transcript variant X3
solute carrier family 12 member 7 isoform X1
solute carrier family 12 member 7 isoform X2
solute carrier family 12 member 7 isoform X3
solute carrier family 12 member 7, transcript variant X4
solute carrier family 12 member 7, transcript variant X5
solute carrier family 12 member 7 isoform X4
solute carrier family 12 member 7 isoform X5
solute carrier family 12 member 7, transcript variant X6
solute carrier family 12 member 7 isoform X6
solute carrier family 12 member 7, transcript variant X7
solute carrier family 12 member 7 isoform X7
NKD inhibitor of WNT signaling pathway 2, transcript variant X1
NKD inhibitor of WNT signaling pathway 2, transcript variant X2
protein naked cuticle homolog 2 isoform X1
protein naked cuticle homolog 2 isoform X2
bromodomain containing 9, transcript variant X5
bromodomain containing 9, transcript variant X6
bromodomain containing 9, transcript variant X7
bromodomain containing 9, transcript variant X8
bromodomain containing 9, transcript variant X1
bromodomain containing 9, transcript variant X2
bromodomain containing 9, transcript variant X3
bromodomain containing 9, transcript variant X4
bromodomain-containing protein 9 isoform X5
bromodomain-containing protein 9 isoform X6
bromodomain-containing protein 9 isoform X7
bromodomain-containing protein 9 isoform X8
bromodomain-containing protein 9 isoform X1
bromodomain-containing protein 9 isoform X2
bromodomain-containing protein 9 isoform X3
bromodomain-containing protein 9 isoform X4
bromodomain containing 9, transcript variant X9
bromodomain-containing protein 9 isoform X9
probable palmitoyltransferase ZDHHC11B, transcript variant X3
probable palmitoyltransferase ZDHHC11B isoform X3
probable palmitoyltransferase ZDHHC11B, transcript variant X1
probable palmitoyltransferase ZDHHC11B, transcript variant X2
probable palmitoyltransferase ZDHHC11B isoform X2
palmitoyltransferase ZDHHC11-like isoform X1
tubulin polymerization promoting protein, transcript variant X1
tubulin polymerization promoting protein, transcript variant X3
tubulin polymerization promoting protein, transcript variant X4
tubulin polymerization promoting protein, transcript variant X7
tubulin polymerization promoting protein, transcript variant X5
tubulin polymerization promoting protein, transcript variant X2
tubulin polymerization-promoting protein isoform X1
tubulin polymerization promoting protein, transcript variant X6
tubulin polymerization-promoting protein isoform X2
centrosomal protein 72, transcript variant X8
centrosomal protein 72, transcript variant X6
centrosomal protein 72, transcript variant X5
centrosomal protein 72, transcript variant X3
centrosomal protein 72, transcript variant X9
centrosomal protein 72, transcript variant X2
centrosomal protein 72, transcript variant X10
centrosomal protein 72, transcript variant X4
centrosomal protein 72, transcript variant X1
centrosomal protein of 72 kDa isoform X4
centrosomal protein of 72 kDa isoform X6
centrosomal protein of 72 kDa isoform X5
centrosomal protein of 72 kDa isoform X3
centrosomal protein of 72 kDa isoform X8
centrosomal protein of 72 kDa isoform X2
centrosomal protein of 72 kDa isoform X9
centrosomal protein of 72 kDa isoform X1
centrosomal protein of 72 kDa isoform X7
centrosomal protein 72, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
solute carrier family 9 member A3, transcript variant X1
solute carrier family 9 member A3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
exocyst complex component 3, transcript variant X1
exocyst complex component 3, transcript variant X3
exocyst complex component 3, transcript variant X4
exocyst complex component 3, transcript variant X2
exocyst complex component 3, transcript variant X5
aryl-hydrocarbon receptor repressor, transcript variant X3
aryl-hydrocarbon receptor repressor, transcript variant X2
aryl-hydrocarbon receptor repressor, transcript variant X1
aryl-hydrocarbon receptor repressor, transcript variant X4
aryl hydrocarbon receptor repressor isoform X3
aryl hydrocarbon receptor repressor isoform X2
aryl hydrocarbon receptor repressor isoform X1
aryl hydrocarbon receptor repressor isoform X4
uncharacterized LOC121816781, transcript variant X2
uncharacterized LOC121816781, transcript variant X1
programmed cell death 6, transcript variant X2
programmed cell death 6, transcript variant X1
programmed cell death protein 6 isoform X2
programmed cell death protein 6 isoform X1
programmed cell death 6, transcript variant X3
programmed cell death protein 6 isoform X3
succinate dehydrogenase complex flavoprotein subunit A
succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial
coiled-coil domain-containing protein 127
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: leucine-rich repeat-containing protein 14B